Menu
Experience
LAW OFFICE OF THANH VAN T. DOAN, LLC
- Focus on family and immigration matters only
- Advocating on behalf of individuals before the Maryland State Courts, Immigration Courts, Board of Immigration Appeals, United States District Court for Maryland, and the United States Court of Appeals for the Fourth Circuit
- Certified Collaborative Law practitioner
- Court-approved mediator
- Court-approved child advocate
JUDICIAL LAW CLERK TO THE HONORABLE SUSAN SOUDER
Circuit Court for Baltimore County, Maryland
- Researched and drafted judicial rulings and memoranda involving administrative appeals, District Court appeals, exceptions to Master’s reports, and complex civil and criminal motions
- Drafted letters in correspondence with attorneys, county agencies, and incarcerated persons
- Researched on the spot issues which arose during the course of a civil/criminal trial
ASPER FELLOWSHIP WITH THE HONORABLE DIANE O. LEASURE
Chief Administrative Judge Circuit Court for Howard County, Maryland
- Researched and drafted judicial rulings and memoranda involving administrative appeals, District Court appeals, exceptions to Magistrate's reports, and complex civil and criminal motions
- Researched on the spot issues which arose during the course of a civil/criminal trial
DIRECTOR, HEALTH CARE DIVISION
PSI International, Inc.
- Supervised pharmaceutical operations worldwide including Europe, Japan, Australia, and the United States
- Developed and implemented the current adverse event reporting process utilizing the Medical Dictionary for Regulatory Activities (MedDRA) for the Center for Drug Evaluation and Review (CDER), Food and Drug Administration
- Created and conducted both live and computer-based training courses (CBT’s) for the pharmaceutical industry
- Created and conducted specialized training in response to specific requests made by clients including but not limited to Pfizer, AstraZeneca, Aventis, Eli Lilly, Johnson & Johnson, Novartis, Eisai, Cephalon, and Gilead
- Presented, educated, and led strategy sessions among company board members and directors regarding MedDRA implementation and its effect company-wide
- Developed yearly business plans including identifying future opportunities and cost and revenue projections
- Moderated meetings with regulatory authorities and pharmaceutical industry representatives to identify issues, propose alternative resolutions, and arrive at satisfactory solutions
